Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

2(33.3%)

Phase 2

1(16.7%)

6Total

N/A(3)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07482865Not ApplicableNot Yet Recruiting

Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support

Role: collaborator

NCT04769362Phase 4Recruiting

Long-term Beta-blocker Therapy After Acute Myocardial Infarction

Role: collaborator

NCT04921189Phase 2Completed

Steroid, Thiamine and Ascorbic Acid for Comatose Out-of-hospital Cardiac Arrest Survivors

Role: collaborator

NCT02715518Not ApplicableCompleted

FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

Role: collaborator

NCT03814421Not ApplicableUnknown

Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding

Role: lead

NCT02224534Phase 4Unknown

Ticagrelor Versus Clopidogrel in Left Ventricular Remodeling After ST-segment Elevation Myocardial Infarction

Role: collaborator

All 6 trials loaded